Advertisement
Heart, Lung and Circulation

Outcomes of Cardiac Transplantation in Western Australia – A Contemporary Single Centre Experience

Published:September 28, 2022DOI:https://doi.org/10.1016/j.hlc.2022.08.020

      Background

      Cardiac transplantation remains the gold standard therapy for select patients with end-stage heart failure and outcomes have improved significantly over the past few decades. We report the 5-year contemporary experience of cardiac transplantation in Western Australia, one of the most remote transplant centres worldwide.

      Methods

      Patients undergoing isolated cardiac transplant at Fiona Stanley Hospital (FSH) from February 2015 until April 2021 were included. Donor details were collected using donor electronic records (Donate Life, Australia). Recipient data was collated from electronic medical records at FSH and the Australia and New Zealand Society of Cardiothoracic Surgery database. The primary outcome measure was all-cause mortality. Secondary outcome measures included postoperative intensive care and total hospital length of stay and rates of acute kidney injury, rejection, serious infections, and cardiac allograft vasculopathy. Frailty indices were also assessed.

      Results

      A total of 60 patients were included (mean age 53±14 yrs, 66.7% male). The commonest indication for transplant was a non-ischaemic cardiomyopathy (46.7%). Mean donor age was 35±12 years and median donor ischaemia time was 171 minutes (IQR=138–240). After median follow up of 3.7 years, there were no mortalities. Postoperative renal failure occurred in 21 (35.0%) patients, pneumonia in four (6.7%), deep sternal wound infection in three (5.1%), acute rejection in 17 (28.3%) and cardiac allograft vasculopathy (CAV) in 23 (38.3%).

      Conclusion

      With recipient and donor criteria comparable to national and international standards, compounded by the challenges of geographic isolation, we report the first published data on contemporary outcomes post isolated cardiac transplantation in Western Australia.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lund L.H.
        • Edwards L.B.
        • Dipchand A.I.
        • Goldfarb S.
        • Kucheryavaya A.Y.
        • Levvey B.J.
        • et al.
        The Registry of the International Society for Heart and Lung Transplantation: thirty-third adult heart transplantation report; focus theme: primary diagnostic indications for transplant.
        J Heart Lung Transplant. 2016; 35: 1158-1169
      1. TSANZ Advisory Committee. Organ Transplantation from Deceased Donors: Consensus Statement on Eligibility Criteria and Allocation Protocols Version 1.3 2017.
        (Available from:)
        • Aili S.R.
        • Lo P.
        • Villanueva J.E.
        • Joshi Y.
        • Emmanuel S.
        • Macdonald P.S.
        Prevention and reversal of frailty in heart failure-a systematic review.
        Circulation. 2021; 86: 14-22
        • Gimeno-Santos E.
        • Coca-Martinez M.
        • Arguis M.J.
        • Navarro R.
        • Lopez-Hernandez A.
        • Castel M.A.
        • et al.
        Multimodal prehabilitation as a promising strategy for preventing physical deconditioning on the heart transplant waiting list.
        Eur J Prev Cardiol. 2020; 27: 2367-2370
        • Macdonald P.S.
        • Gorrie N.
        • Brennan X.
        • Aili S.R.
        • De Silva R.
        • Jha S.R.
        • et al.
        The impact of frailty on mortality after heart transplantation.
        J Heart Lung Trasplant. 2021; 40: 87-94
        • Reid C.M.
        • Rockell M.
        • Skillington P.D.
        • Shardey G.C.
        • Smith J.A.
        • Yii M.
        • et al.
        Initial twelve months experience and analysis for 2001-2002 from the Australasian Society of Cardiac and Thoracic Surgeons--Victorian database project.
        Heart Lung Circ. 2004; 13: 291-297
        • Shardey G.C.
        • Williams-Spence J.
        • Tran L.
        • Solman N.
        • McLaren J.
        • Marrow N.
        • et al.
        The Australian and New Zealand Society of Cardiac and Thoracic Surgeons Cardiac Surgery Database Program National Annual Report 2018.
        Monash University, 2019 (Report No.: 12)
        • Stewart S.
        • Winters G.L.
        • Fishbein M.C.
        • Tazelaar H.D.
        • Kobashigawa J.
        • Abrams J.
        • et al.
        Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.
        J Heart Lung Transplant. 2005; 24: 1710-1720
        • Colvin M.M.
        • Cook J.L.
        • Chang P.P.
        • Hsu D.T.
        • Kiernan M.S.
        • Kobashigawa J.A.
        • et al.
        Sensitization in heart transplantation: emerging knowledge: a scientific statement from the American Heart Association.
        Circulation. 2019; 139: e553-e578
        • Khush K.K.
        • Hsich E.
        • Potena L.
        • Cherikh W.S.
        • Chambers D.C.
        • Harhay M.O.
        • et al.
        The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult heart transplantation report - 2021; focus on recipient characteristics.
        J Heart Lung Transplant. 2021; 40: 1035-1049
        • Mehra M.R.
        • Crespo-Leiro M.G.
        • Dipchand A.
        • Ensminger S.M.
        • Hiemann N.E.
        • Kobashigawa J.A.
        • et al.
        International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy.
        J Heart Lung Transplant. 2010; 29: 717-727
        • Wilson M.E.
        • Vakil A.P.
        • Kandel P.
        • Undavalli C.
        • Dunlay S.M.
        • Kennedy C.C.
        Pretransplant frailty is associated with decreased survival after lung transplantation.
        J Heart Lung Transplant. 2016; 35: 173-178
        • Jha S.R.
        • Hannu M.K.
        • Gore K.
        • Chang S.
        • Newton P.
        • Wilhelm K.
        • et al.
        Cognitive impairment improves the predictive validity of physical frailty for mortality in patients with advanced heart failure referred for heart transplantation.
        J Heart Lung Transplant. 2016; 35: 1092-1100
        • Khush K.K.
        • Cherikh W.S.
        • Chambers D.C.
        • Goldfarb S.
        • Hayes Jr., D.
        • Kucheryavaya A.Y.
        • et al.
        The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-Fifth Adult Heart Transplantation Report-2018; Focus Theme: Multiorgan Transplantation.
        J Heart Lung Transplant. 2018; 37: 1155-1168
        • Monteagudo Vela M.
        • García Sáez D.
        • Simon A.R.
        Current approaches in retrieval and heart preservation.
        Ann Cardiothorac Surg. 2018; 7: 67-74
        • John M.M.
        • Shih W.
        • Estevez D.
        • Martens T.P.
        • Bailey L.L.
        • Razzouk A.J.
        • et al.
        Interaction between ischemic time and donor age on adult heart transplant outcomes in the modern era.
        Ann Thorac Surg. 2019; 108: 744-748
        • Stobierska-Dzierzek B.
        • Awad H.
        • Michler R.E.
        The evolving management of acute right-sided heart failure in cardiac transplant recipients.
        J Am Coll Cardiol. 2001; 38: 923-931
        • Bakhtiyar S.S.
        • Godfrey E.L.
        • Ahmed S.
        • Lamba H.
        • Morgan J.
        • Loor G.
        • et al.
        Survival on the heart transplant waiting list.
        JAMA Cardiol. 2020; 5: 1227-1235
        • Goldstein B.A.
        • Thomas L.
        • Zaroff J.G.
        • Nguyen J.
        • Menza R.
        • Khush K.K.
        Assessment of heart transplant waitlist time and pre- and post-transplant failure: a mixed methods approach.
        Epidemiology. 2016; 27: 469-476
        • Nilsson J.
        • Jernryd V.
        • Qin G.
        • Paskevicius A.
        • Metzsch C.
        • Sjöberg T.
        • et al.
        A nonrandomized open-label phase 2 trial of nonischemic heart preservation of human heart transplantation.
        Nat Commun. 2020; 11: 2976